← Compound index
COMPOUND RECORD / VASONIN

VasoninВазонин

A historical name for a polypeptide preparation derived from blood-vessel walls. The available sources do not establish its precise composition or its relationship to Vasolin.

Source linked

What the studies found

Animal research · 1986

[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].

Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.

Study notes · methods, sources and limitations

Participants or model Rabbits with diet-induced peroxidation syndrome

Important limitations

  • This partial experimental effect does not establish vascular protection or a favorable bleeding-risk balance in humans. Full methods, reporting completeness and independent replication remain to be appraised.

Farmakologiia i toksikologiia · PMID 3817141 · Original journal report

Original source or citation ↗

Study results and tables ↗

Animal research · 1984

[Effect of vascular wall polypeptides on the hemostatic system].

Vasonin prolonged clotting time, altered platelet counts and delayed aggregation in a rat experiment.

Study notes · methods, sources and limitations

Participants or model Rats exposed to a bovine vascular-wall polypeptide fraction

Important limitations

  • Human thrombosis prevention, clinical bleeding risk and formulation equivalence remain unestablished. Full methods, reporting completeness and independent replication remain to be appraised.

Farmakologiia i toksikologiia · PMID 6714401 · Original journal report

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About Vasonin

Research background

Historical reports refer to a vascular-wall polypeptide preparation as Vasonin. They do not specify whether its manufacturing process matched that of Vasolin.

Compound class
Archival preparation lead
Research collection
Peptide bioregulation · editorial grouping
Institutions in linked studies
See individual study records
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

The published studies use animal or cell models.

Study methods

Study records describe the tested models, comparators and reported outcomes.

Independent replication

New citations are not automatically independent replication; shared programs and translated reports require cohort checks

Source access

New indexed primary abstracts and/or report reproductions linked; review depth shown per source

Safety evidence

Reported tolerability is not proof of safety; uncommon harms and long-term outcomes remain unresolved

Open a topic for the evidence assessment.

More findings, background and history

What remains unclear

The available experimental studies leave human benefit and safety uncertain.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.

Browse original study records ↗

Explore the expanded peptide research collection and unresolved source trails ↗

03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Animal research · 1986

[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].

Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.

Study notes and original source
1986Animal / experimentalEnglish abstract

[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].

· Original journal report

Kuzik BI, Mishchenko VP, Khavinson VKh, Morozov VG, Gritsaĭ NN · Farmakologiia i toksikologiia · PMID 3817141

Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.

Population / setting
Rabbits with diet-induced peroxidation syndrome
Source reviewed
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Study limitations
  • This partial experimental effect does not establish vascular protection or a favorable bleeding-risk balance in humans.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Reviewed 2026-10-05.

Read the source ↗

Animal research · 1984

[Effect of vascular wall polypeptides on the hemostatic system].

Vasonin prolonged clotting time, altered platelet counts and delayed aggregation in a rat experiment.

Study notes and original source
1984Animal / experimentalEnglish abstract

[Effect of vascular wall polypeptides on the hemostatic system].

· Original journal report

Kuznik BI, Khavinson VKh, Morozov VG, Arushanian LG, Tsybikov NN · Farmakologiia i toksikologiia · PMID 6714401

Vasonin prolonged clotting time, altered platelet counts and delayed aggregation in a rat experiment.

Population / setting
Rats exposed to a bovine vascular-wall polypeptide fraction
Source reviewed
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Study limitations
  • Human thrombosis prevention, clinical bleeding risk and formulation equivalence remain unestablished.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Reviewed 2026-10-05.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗